Pyxis Oncology, Inc. reports

Location: Boston, MA
Fiscal year end: 31 December

Pyxis Oncology, Inc. has filed 325 SEC EDGAR filings since 12 Jul 2019

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 201-225 of 325 matching filings.

Per page

25

Current page

9

4

FORM 4 SUBMISSION

Filing date: 28 Mar 2023
Reporting date: 24 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Mar 2023
Reporting date: 24 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Mar 2023
Reporting date: 24 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Mar 2023
Reporting date: 24 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Mar 2023
Reporting date: 24 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Mar 2023
Reporting date: 24 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-40881

8-K

Filing date: 28 Mar 2023
Reporting date: 28 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-92951

SC 13G A 2 PYXIS ONCOLOGY

Filing date: 23 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

PRIMARY DOCUMENT

Filing date: 23 Mar 2023
Reporting date: 17 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-270753

S-8

Filing date: 22 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-40881

10-K

Filing date: 22 Mar 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-40881

8-K

Filing date: 22 Mar 2023
Reporting date: 22 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 21 Mar 2023
Reporting date: 17 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-40881

8-K

Filing date: 16 Mar 2023
Reporting date: 16 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-92951

SC 13G/A

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-92951

AMENDMENT NO. 1

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-92951

PYXIS ONCOLOGY, INC.

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-92951

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-92951

SC 13G/A PYXIS ONCOLOGY

Filing date: 13 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-92951

SC 13G filing

Filing date: 08 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2023
Reporting date: 03 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2023
Reporting date: 03 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2023
Reporting date: 03 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-40881

8-K

Filing date: 01 Dec 2022
Reporting date: 01 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

EFFECT File 333-268100

EFFECT filing

Filing date: 14 Nov 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .